Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder
Essawi, M., Elbagoury, N., Sayed, O., Aglan, M., Ibrahim, M., Soliman, H., Fateen, E. (2018). Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder. EKB Journal Management System, 7(2), -. doi: 10.4103/MXE.MXE_8_18
Mona L. Essawi; Nagham M. Elbagoury; Ola M. Sayed; Mona S. Aglan; Mona M. Ibrahim; Hala N. Soliman; Ekram M. Fateen. "Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder". EKB Journal Management System, 7, 2, 2018, -. doi: 10.4103/MXE.MXE_8_18
Essawi, M., Elbagoury, N., Sayed, O., Aglan, M., Ibrahim, M., Soliman, H., Fateen, E. (2018). 'Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder', EKB Journal Management System, 7(2), pp. -. doi: 10.4103/MXE.MXE_8_18
Essawi, M., Elbagoury, N., Sayed, O., Aglan, M., Ibrahim, M., Soliman, H., Fateen, E. Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder. EKB Journal Management System, 2018; 7(2): -. doi: 10.4103/MXE.MXE_8_18

Mutation analysis of the arylsulfatase B gene among Egyptian patients with Maroteaux–Lamy disorder

Middle East Journal of Medical Genetics
Volume 7, Issue 2, July 2018  XML PDF (427.31 K)
DOI: 10.4103/MXE.MXE_8_18
View on SCiNiTO View on SCiNiTO
Authors
Mona L. Essawi; Nagham M. Elbagoury; Ola M. Sayed; Mona S. Aglan; Mona M. Ibrahim; Hala N. Soliman; Ekram M. Fateen
Abstract
Background
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) (OMIM: # 253200), is an autosomal recessive lysosomal storage disorder. It is caused by deficiency of the enzyme arylsulfatase B (), also known as N-acetylgalactosamine-4-sulfatase. is responsible for the degradation of the glycosaminoglycans dermatan sulfate and chondroitin 4-sulfate. Deficiency of the enzyme leads to accumulation of partially degraded dermatan sulfate in the lysosomes especially in connective tissues leading to clinical complications.
Aim
This study aimed at identifying the molecular basis of MPS VI (Mucopolysaccharidosis VI) among 15 Egyptian patients.
Method
Patients were from 15 families, age ranged from 1year and 5 months to 11 years and 9 months(5.19±0.8) with parental consanguinity in 11 families out of 15 (73.3%). All patients were subjected to all necessary clinical, radiological and biochemical assessments. Molecular assessment was carried out by sequencing the 8 coding exons of the gene for the fifteen studied patients.
Results
The disease causing mutations were revealed in 13 patients. Four novel mutations; c.257delA, c.189insA, p.Ser94Leu and p.Leu51Pro were identified as well as four previously reported mutations; p.Leu82Arg, p.Ser96Arg, p.Arg160X and p.Arg160Gln.
Conclusion
The study highlights the heterogeneity of the mutational pattern which was obvious in finding novel mutations in homozygous forms in approximately 40% of the studied patients. Exons 1 and 2 seem to carry most of the mutations in the Egyptian MPS VI patients. Arginine at position 160 seems to be the most abundant mutational hot spot in the Egyptian MPS VI patients.
Keywords
ARSB gene; dermatan sulphate; MPS VI
Statistics
Article View: 60
PDF Download: 47